Published: Feb 28, 2026
Written by Klarity Editorial Team
Published: Feb 28, 2026

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can access treatment without leaving home. The good news: Yes, you can get medication for binge eating disorder through telehealth — and it’s both legal and increasingly common across the United States.
With telehealth regulations now well-established following the pandemic, getting evaluated and treated for BED online has become a safe, accessible option for millions of Americans. Whether you’re in a rural area with limited specialists, juggling a busy schedule, or simply prefer the privacy of virtual care, understanding how telehealth BED treatment works can be your first step toward recovery.
Binge eating disorder is the most common eating disorder in the United States, affecting millions of people. It’s characterized by recurring episodes of eating large amounts of food in a short time while feeling out of control, typically at least once weekly for three months or more. Unlike bulimia, BED doesn’t involve compensatory behaviors like purging.
While therapy remains a cornerstone of BED treatment, medication can play a valuable role — especially when combined with counseling and nutritional support. The challenge has traditionally been access: eating disorder specialists are often concentrated in urban areas, and many patients face long wait times or feel uncomfortable seeking in-person care.
Telehealth has transformed this landscape. Today, you can connect with licensed healthcare providers who specialize in eating disorders from anywhere in your state, often with appointments available within days rather than months.
The medications most commonly prescribed via telehealth for binge eating disorder are non-controlled substances — meaning they aren’t regulated under the strict federal rules that govern stimulants or opioids. The two most frequently prescribed options are:
Originally FDA-approved for seizures and migraine prevention, topiramate is commonly used off-label for BED. Research suggests it can help reduce binge frequency and support impulse control. Providers typically start with low doses and gradually increase to minimize side effects.
Important considerations:
FDA-approved for depression and smoking cessation, bupropion is another off-label option for BED. Studies show it may help reduce binge episodes in some patients by affecting brain chemistry related to impulse control and mood.
Important considerations:
Both medications are fully legal to prescribe via telehealth because they aren’t controlled substances. This means the strict in-person requirements that apply to medications like Adderall or Vyvanse don’t apply here.
Understanding the legal framework helps you know what to expect from legitimate telehealth providers.
No federal in-person requirement exists for prescribing non-controlled medications via telehealth. The Ryan Haight Act — the 2008 law that requires an in-person visit before prescribing controlled substances online — was never intended to restrict medications like topiramate or bupropion.
This means that federally, a healthcare provider licensed in your state can evaluate you via video visit and prescribe these BED medications without ever seeing you in person, as long as they meet the standard of care.
While BED treatments we’re discussing aren’t affected, it’s worth noting that Vyvanse (lisdexamfetamine) — the only FDA-approved medication specifically for BED — is a controlled substance (Schedule II stimulant). The DEA’s COVID-era flexibilities that allowed telehealth prescribing of controlled substances have been extended through December 31, 2026, but these medications face stricter requirements.
Most telehealth platforms don’t prescribe controlled stimulants for BED due to regulatory complexity and abuse potential, focusing instead on the non-controlled options that offer more straightforward access.
While federal law sets the baseline, state laws add additional requirements that vary significantly. Here’s what matters most:
California, New York, Texas, Florida, Michigan, Wisconsin, and South Carolina are among states that don’t require an in-person visit for non-controlled medication prescriptions via telehealth. In California, the law explicitly states that a telehealth exam — even conducted via video or online questionnaire — can satisfy the ‘prior examination’ requirement if it meets the appropriate standard of care.
Alabama, Georgia, and New Hampshire require periodic in-person follow-ups for ongoing telemedicine care:
Even in these states, you can start treatment entirely via telehealth — the in-person requirement only applies to long-term continuation of care.
Regardless of state rules, your telehealth provider must be licensed in the state where you’re physically located during the appointment. This is non-negotiable. A California-licensed doctor cannot treat you if you’re in Texas, even via video.
Reputable telehealth platforms verify your location at the start of each visit to ensure compliance. This protects both you and the provider.
Physicians can prescribe these medications in all states via telehealth, assuming they’re licensed in your state and follow state-specific telehealth regulations.
NP prescribing authority varies significantly by state:
Full Practice Authority States (34 states + DC): NPs can evaluate and prescribe independently without physician oversight. Recent additions include Wisconsin and Michigan (both passed NP independence laws in 2025), joining states like California, New York, and New Hampshire.
Collaborative Practice States: States like Texas, Florida, Georgia, and Alabama require NPs to work under a formal agreement with a physician. The NP can still prescribe your BED medication, but a physician oversees their practice. This typically doesn’t affect your care experience — it’s a behind-the-scenes regulatory requirement.
At Klarity Health, our network includes both physicians and nurse practitioners licensed across multiple states, ensuring you can access care whether your state requires physician oversight or allows independent NP practice.
PAs can prescribe non-controlled medications in all states under physician supervision. Like NPs in collaborative states, they work within a formal agreement structure but can provide the same quality BED treatment.
Your first appointment will be comprehensive — expect 30-45 minutes of detailed questions. A reputable provider will ask about:
The provider will determine if you meet DSM-5 criteria for BED:
Don’t be surprised when asked to verify your identity and physical location. This is required by law in many states and ensures the provider is licensed to treat you. It’s not about distrust — it’s about regulatory compliance and your safety.
If medication is appropriate, your provider should discuss:
Legitimate telehealth providers understand that medication alone isn’t the complete answer for BED. The best outcomes combine medication with:
At Klarity Health, our providers take a holistic approach — we can prescribe medication where appropriate while also connecting you with therapy and nutritional support resources, accepting both insurance and cash pay for maximum accessibility.
The rapid growth of telehealth has attracted some bad actors. Here’s how to protect yourself:
Prescription promises before evaluation: Any service guaranteeing a prescription before assessing you is not following proper medical standards.
Inadequate evaluation: If your ‘visit’ consists of a 5-minute questionnaire with no provider interaction, that’s not legitimate medical care.
Selling medication directly: Reputable providers send prescriptions to licensed pharmacies (retail or mail-order). They don’t ship pills to you from their own warehouse.
No discussion of alternatives: A provider who only offers medication without mentioning therapy or other options isn’t providing comprehensive care.
Overprescribing: Starting multiple new medications simultaneously or prescribing unusually high doses should raise concerns.
Thorough medical history: Expect detailed questions and a comprehensive evaluation, not a checkbox form.
Licensed providers: Verify your provider is licensed in your state through your state medical or nursing board website.
Informed consent: You’ll sign consent forms explaining telehealth limitations, privacy protections, and treatment risks.
Regular follow-up: Quality providers schedule ongoing appointments to monitor your progress and adjust treatment.
Transparent pricing: You should know costs upfront, whether using insurance or paying cash.
Accessible support: Legitimate services offer ways to contact your provider between visits if issues arise.
Pharmacy integration: Prescriptions go to established pharmacies, not directly from the telehealth company.
The DEA and state boards have cracked down on problematic telehealth prescribing. A high-profile example: executives from a telehealth ADHD startup were indicted in 2024 for unsafe Adderall prescribing practices that contributed to national shortages and patient harm.
These enforcement actions have actually strengthened legitimate telehealth by establishing clearer standards and weeding out bad actors. Reputable platforms now implement strict protocols to ensure compliance and patient safety.
You’re likely well-suited for telehealth BED treatment if you:
Telehealth providers will screen you out or refer you to in-person specialists if you have:
History of anorexia or bulimia: Bupropion is contraindicated due to seizure risk in patients with eating disorders involving purging.
Seizure disorders: Both bupropion and topiramate can affect seizure threshold and require careful neurological monitoring.
Pregnancy or planning pregnancy: Topiramate carries significant fetal risks. Most telehealth providers won’t initiate it in pregnant patients and will require effective contraception.
Severe medical instability: If BED has caused urgent health complications (severe metabolic issues, uncontrolled diabetes, extremely high blood pressure), you may need in-person evaluation first.
Active suicidal ideation: While bupropion treats depression, if you’re currently experiencing suicidal thoughts, you need immediate in-person psychiatric care.
Need for controlled medications: If evaluation suggests you might benefit from Vyvanse (the FDA-approved BED medication) or other controlled substances, telehealth options are more limited, and you may need in-person care.
Substance use concerns: Active alcohol abuse is a contraindication for bupropion. Providers will assess for substance use disorders that might complicate treatment.
Many states require healthcare providers to check a Prescription Drug Monitoring Program database before prescribing certain medications. These databases track controlled substance prescriptions to prevent ‘doctor shopping’ and identify potential abuse.
Good news for BED treatment: Since topiramate and bupropion are not controlled substances, most states don’t mandate PMP checks before prescribing them.
However, your telehealth provider may still review the PMP as a safety precaution to:
This is considered good medical practice, even when not legally required. It’s part of comprehensive care, not a sign of distrust.
When starting BED medication via telehealth, expect close follow-up:
Week 2-4: First check-in to assess how you’re tolerating the medication, address initial side effects, and determine if dose adjustment is needed.
Month 2-3: Evaluation of treatment effectiveness — are binge episodes decreasing? How’s your mood? Any concerning side effects?
Ongoing: Monthly or bimonthly follow-ups, depending on your stability and state requirements.
Because these medications aren’t controlled substances, providers can often authorize refills for 6-12 months (depending on state pharmacy laws), meaning you won’t need a new prescription every month.
However, refills don’t replace follow-up appointments. You’ll still need regular check-ins to:
Remember that Alabama, Georgia, and New Hampshire require periodic in-person visits for ongoing telehealth care (typically yearly). Your telehealth provider will help you schedule these or connect you with a local provider for the in-person component while continuing your overall care via telehealth.
Most major insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to regulations that became permanent post-pandemic. However, coverage specifics vary:
Medicare: Covers telehealth for mental health services, including eating disorder treatment, through at least 2026.
Medicaid: Coverage varies by state, but most states have expanded telehealth coverage.
Private insurance: Most commercial plans cover telehealth, but check whether your specific plan covers the provider network you’re considering.
At Klarity Health, we accept most major insurance plans and can verify your coverage before your first appointment. We also offer transparent cash-pay pricing for those without insurance or who prefer not to use it.
If paying out-of-pocket, typical costs are:
Cash-pay telehealth is often significantly less expensive than traditional in-person care when factoring in time off work, transportation, and other indirect costs.
Both telehealth visits and BED medications typically qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) reimbursement, providing additional savings if you have these accounts.
Look for telehealth platforms that:
Before your appointment, confirm:
Gather information about:
The quality of your treatment depends on the information you provide. Be candid about:
If prescribed medication:
The telehealth landscape continues evolving. Key recent developments:
DEA Controlled Substance Flexibilities Extended: The DEA’s temporary rule allowing telehealth prescribing of controlled substances has been extended through December 31, 2026. While this doesn’t directly affect non-controlled BED medications, it signals continued federal support for telehealth access.
Permanent Rule Pending: The DEA is working on permanent regulations for telehealth controlled substance prescribing, expected by the end of 2026. These will likely require some in-person component for stimulants and other controlled medications.
New Hampshire (2025): Passed legislation explicitly allowing telehealth prescribing of Schedule II-IV medications without an initial in-person visit, requiring only annual in-person follow-up.
Wisconsin and Michigan (2025): Both states granted full practice authority to nurse practitioners, expanding the pool of providers who can independently prescribe BED medications.
New York (May 2025): Adopted rules requiring in-person exams before prescribing controlled substances via telehealth (with limited exceptions), aligning with anticipated federal rules. Non-controlled medications remain fully accessible via telehealth.
California (2025): Further clarified that asynchronous telehealth (questionnaires, messaging) can satisfy examination requirements if it meets the standard of care.
These updates generally reflect a trend toward making telehealth flexibilities permanent while adding guardrails for controlled substances to prevent abuse.
At Klarity Health, we understand that seeking help for binge eating disorder takes courage. Our telehealth platform is designed to make that help accessible, affordable, and effective.
Provider Availability: We maintain a network of licensed psychiatrists and nurse practitioners across multiple states, often with appointments available within days, not weeks or months.
Transparent Pricing: Whether you’re using insurance or paying cash, you’ll know your costs upfront — no surprise bills or hidden fees.
Insurance and Cash Pay: We accept most major insurance plans and offer competitive cash-pay rates, giving you flexibility in how you pay for care.
Comprehensive Approach: Our providers don’t just prescribe medication — we can connect you with therapy, nutritional support, and other resources for holistic BED treatment.
Convenient Access: Meet with your provider from home, during lunch breaks, or whenever fits your schedule. No commuting, no waiting rooms.
Ongoing Support: We’re here for the long term with regular follow-ups, medication management, and accessible support between appointments.
If you’re struggling with binge eating disorder, telehealth removes many barriers that once stood between you and effective treatment. You can now access specialized care regardless of where you live, often with greater privacy, convenience, and affordability than traditional in-person care.
The bottom line: Yes, you can get medication for binge eating disorder via telehealth legally and safely across the United States. Non-controlled medications like topiramate and bupropion are fully accessible through video visits with licensed providers in your state, without federal requirements for in-person exams.
While some states require periodic in-person follow-ups for long-term care, you can start treatment entirely online in most cases. The key is choosing a reputable provider who conducts thorough evaluations, discusses all treatment options, and provides ongoing support.
Remember that medication is just one tool in BED recovery. The most effective treatment combines medication (when appropriate) with therapy, nutritional counseling, and support — a comprehensive approach that telehealth platforms like Klarity Health can facilitate.
You don’t have to face binge eating disorder alone, and you don’t have to wait months for an appointment or drive hours to see a specialist. Help is available now, from the privacy and comfort of home.
If you’re ready to take the next step toward recovery, schedule an evaluation with Klarity Health today. Our experienced providers are ready to help you develop a personalized treatment plan that works for your life.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications — these were never subject to Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
U.S. Department of Health and Human Services. ‘DEA Extends Telehealth Prescribing Flexibilities Through 2026.’ HHS.gov Press Release, January 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ August 2025. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/
Center for Connected Health Policy. ‘Online Prescribing State Laws.’ CCHP State Telehealth Policy Database, November-December 2025. https://www.cchpca.org/topic/online-prescribing/
U.S. Department of Health and Human Services. ‘Prescribing Controlled Substances Via Telehealth.’ Telehealth.HHS.gov, November 2024. https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth
Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ January 2025. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
Find the right provider for your needs — select your state to find expert care near you.